Clinical Trials Browser

Withdrawn × OTHER × toripalimab × Clear all

NCT05650203 2023-04-05

A Study of JS009 Monotherapy and JS009 as a Triple Combination Therapy in Patients With Advanced Malignancies

Phase 1 Withdrawn

Primary Condition: Advanced Tumors

NCT05253105 2022-05-31

A Clinical Study of TAB006 in Patients With Previously Treated, Advanced Malignancies

Phase 1 Withdrawn

Neoplasms

NCT03919383 2019-06-03

Phase II of Lenvatinib Plus Toripalimab for Advanced HCC

Phase 2 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular